Date: 2024/06/26
Time: 4.00 pm - 5.00 pm
Venue
An der Neuen Bergstraße 17, Pfungstadt, Germany
Information
Website: https://clinical.r-biopharm.com/indications/therapeutic-drug-monitoring/
Contact: j.kessels@r-biopharm.de
We have the pleasure to invite you to our upcoming webinar for Therapeutic Drug Monitoring (TDM) on the 26th of June at 4 pm CET.
The webinar will be presented by Stephane Paul, Professor / Practitioner (PUPH) in Immunology and Vaccinology at the Faculty of Medicine in Saint-Etienne (France) since 2008. He is the PI of the team 15 of the CIRI named Pathophysiology and biotherapies of mucosal infections (GIMAP) in Lyon. He’s also heading the Immunology department of the CHU Saint-Etienne with a strong expertise in the monitoring of biotherapies and which is accredited as a center of excellence for the TDM. In this webinar Stephane Paul will explain the difference(s) between drug-sensitive and drug-tolerant assays and what consequences the choice of an assay has on your (clinical) decision.
The TDM webinar is for everyone with interest in TDM, clinicians like gastroenterologists, dermatologists, theumatologists, pharmacists, lab doctors, lab technicians and gastro nurses. R-Biopharm AG from Germany and apDia bvba from Belgium are licensed by the KU Leuven to commercialize the monoclonal antibodies from KU Leuven.
We hope that you all will join.
Our Experts:
Dr. Andreas Simons, Director Product Management Clinical Diagnostics
Nadine Porscha, Product manager TDM
Gabor Kuhn, Junior Product Manager TDM
James Kessels, product specialist Gastroenterology and TDM